Post
AWAK obtains breakthrough device designation for KDPP tool
AWAK Technologies has obtained breakthrough device designation from the US Food and Drug Administration for its AI-enabled kidney disease progression …
Accelerate Diagnostics and Bruker to validate Arc system usage
Accelerate Diagnostics and Bruker have signed a collaboration and quality agreement to validate the use of the Arc system with …
Revvity introduces EONIS Q system to screen SCID and SMA in newborns
Revvity has introduced a CE-IVD declared platform, EONIS Q, to enable molecular testing in newborns for severe combined immunodeficiency (SCID) …
Inari Medical enrols first patient in FlowTriever System trial
Inari Medical has enrolled the first patient in its PEERLESS II study, which is evaluating the FlowTriever System in treating …
FDA grants IDE to RTI Surgical for breast reconstruction device trial
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to RTI Surgical’s allograft dermis, opening the …
Ricoh partners with 3D printing firm to drive up access for clinicians
Japanese imaging and electronics company, Ricoh, has partnered with a Belgian 3D printing firm in a bid to produce 3D …
AWAK obtains breakthrough device designation for KDPP tool
AWAK Technologies has obtained breakthrough device designation from the US Food and Drug Administration for its AI-enabled kidney disease progression …
Accelerate Diagnostics and Bruker to validate Arc system usage
Accelerate Diagnostics and Bruker have signed a collaboration and quality agreement to validate the use of the Arc system with …
Revvity introduces EONIS Q system to screen SCID and SMA in newborns
Revvity has introduced a CE-IVD declared platform, EONIS Q, to enable molecular testing in newborns for severe combined immunodeficiency (SCID) …
Inari Medical enrols first patient in FlowTriever System trial
Inari Medical has enrolled the first patient in its PEERLESS II study, which is evaluating the FlowTriever System in treating …
FDA grants IDE to RTI Surgical for breast reconstruction device trial
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to RTI Surgical’s allograft dermis, opening the …
External controls can augment low populations in rare disease trials
Data collection has been an integral part of conducting clinical trials. With the introduction of new technologies such as machine …
Augmented & Virtual reality in the classroom
During MEDICA 2023, Dr. Marc-Angelo Bisotti, Chairman of the Board and …
FDA clears BrainSpec’s AI-powered MRS platform
The US Food and Drug Administration (FDA) has cleared BrainSpec’s magnetic resonance spectroscopy (MRS) platform, meaning clinicians will now have …
GE HealthCare debut new AI tech at RSNA 2023
GE HealthCare is exhibiting more than 40 new innovations during the Radiological Society of North America’s (RSNA) Annual Meeting in Chicago, …